Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Santos

Showing results (71-80 of 4,187) with videos related to

Pageof 419
Sort By:
Cellular Microbiology|January 16, 2015
Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathwaysAndrew S Santos, B Brett Finlay
Birth Defects Research. Part C, Embryo Today : Reviews|June 28, 2016
Prenatal exposure: The effects of prenatal cocaine and methamphetamine exposure on the developing childLynne M Smith, Lucinda S Santos
Immunotherapy|July 20, 2010
Cancer vaccines: a new therapeutic alternative for lung cancer therapy?Luis E Raez, Edgardo S Santos
Revista De Saude Publica|April 4, 2006
[Population-based study of the epidemiology of diagnostic test ordering]Marcelo F Capilheira, Iná S Santos
Blood Reviews|November 25, 2010
JAK2 inhibitors: what's the true therapeutic potential?Fabio P S Santos, Srdan Verstovsek
Current Opinion in Hematology|February 7, 2013
What is next beyond janus kinase 2 inhibitors for primary myelofibrosis?Fabio P S Santos, Srdan Verstovsek
Anti-Cancer Agents in Medicinal Chemistry|May 16, 2012
JAK2 inhibitors for myelofibrosis: why are they effective in patients with and without JAK2V617F mutation?Fabio P S Santos, Srdan Verstovsek
Journal of Mass Spectrometry : JMS|April 22, 2017
On-bead MALDI-MS monitoring of solid-supported N-acyliminium ion reactionsF M Nachtigall, L S Santos
Expert Opinion on Pharmacotherapy|May 27, 2014
Efficacy of ruxolitinib for myelofibrosisFabio P S Santos, Srdan Verstovsek
FEBS Letters|July 25, 2012
Yeast as a model system for studying lipid homeostasis and functionAline X S Santos, Howard Riezman
Pageof 419

Showing results (71-80 of 4,187) with videos related to

Sort By:
Pageof 419
Cellular Microbiology|January 16, 2015
Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathwaysAndrew S Santos, B Brett Finlay
Birth Defects Research. Part C, Embryo Today : Reviews|June 28, 2016
Prenatal exposure: The effects of prenatal cocaine and methamphetamine exposure on the developing childLynne M Smith, Lucinda S Santos
Immunotherapy|July 20, 2010
Cancer vaccines: a new therapeutic alternative for lung cancer therapy?Luis E Raez, Edgardo S Santos
Revista De Saude Publica|April 4, 2006
[Population-based study of the epidemiology of diagnostic test ordering]Marcelo F Capilheira, Iná S Santos
Blood Reviews|November 25, 2010
JAK2 inhibitors: what's the true therapeutic potential?Fabio P S Santos, Srdan Verstovsek
Current Opinion in Hematology|February 7, 2013
What is next beyond janus kinase 2 inhibitors for primary myelofibrosis?Fabio P S Santos, Srdan Verstovsek
Anti-Cancer Agents in Medicinal Chemistry|May 16, 2012
JAK2 inhibitors for myelofibrosis: why are they effective in patients with and without JAK2V617F mutation?Fabio P S Santos, Srdan Verstovsek
Journal of Mass Spectrometry : JMS|April 22, 2017
On-bead MALDI-MS monitoring of solid-supported N-acyliminium ion reactionsF M Nachtigall, L S Santos
Expert Opinion on Pharmacotherapy|May 27, 2014
Efficacy of ruxolitinib for myelofibrosisFabio P S Santos, Srdan Verstovsek
FEBS Letters|July 25, 2012
Yeast as a model system for studying lipid homeostasis and functionAline X S Santos, Howard Riezman
Pageof 419